Staar Surgical (STAA) Net Shares Issued and Repurchased (2021 - 2026)
Staar Surgical's (STAA) quarterly Net Shares Issued and Repurchased came in at $85000.0 in Q2 2026, down 39.29% on a YoY basis from $140000.0 in Q2 2025, and down 91.43% quarter-over-quarter from $992000.0 in Q1 2026.
Analysis
Staar Surgical (STAA) Net Shares Issued and Repurchased (2021 - 2026) Analysis & Trends
Staar Surgical (STAA) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $85000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Shares Issued and Repurchased fell 39.29% year-over-year to $85000.0; the trailing twelve-month figure through Apr 2026 stood at $85000.0 (down 39.29% YoY), and the FY2026 full-year result was $992000.0, up 55.0% from the prior year.
- Net Shares Issued and Repurchased retreated to $85000.0 in Q2 2026 per STAA's latest filing, from $992000.0 in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $992000.0 in Q1 2026 and bottomed at $85000.0 in Q2 2026.
- Historically, Net Shares Issued and Repurchased has averaged $500111.1 across 5 years, with a median of $496000.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Net Shares Issued and Repurchased jumped 78.75% in 2022, then tumbled 73.23% in 2025.
- Over 5 years, Net Shares Issued and Repurchased stood at $488000.0 in 2022, then soared by 53.48% to $749000.0 in 2023, then retreated by 14.55% to $640000.0 in 2024, then plunged by 78.12% to $140000.0 in 2025, then plunged by 39.29% to $85000.0 in 2026.
- According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $85000.0, $992000.0, and $140000.0 for Q2 2026, Q1 2026, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | Staar Surgical | 1.18 Bn | 996.53 Mn | 69.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 3, 2026 | 85,000.00 |
| Jan 2, 2026 | 992,000.00 |
| Mar 28, 2025 | 140,000.00 |
| Dec 27, 2024 | 640,000.00 |
| Mar 29, 2024 | 523,000.00 |
| Dec 29, 2023 | 749,000.00 |
| Mar 31, 2023 | 496,000.00 |
| Dec 30, 2022 | 488,000.00 |
| Apr 1, 2022 | 388,000.00 |
| Dec 31, 2021 | 273,000.00 |